Preclinical models of infectious diseases
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $811,973
Award facts
- Contract value 70% obligated
-
- $811,973.00 Current, with exercised options
- $1,151,741.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $4,250 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $167,759 | |
| Exercise an Option | $167,759 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $472,205 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of higher learning, will provide services such as testing candidate treatments for HIV/AIDS, hepatitis, and tuberculosis in animal models. The university has extensive experience supporting the federal government's medical research and public health initiatives through prime and sub-contracts, including work on high-consequence pathogens like Ebola. The contract has no set-aside designation.
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 10, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $811,973 on 75N93022F00002. Its potential value, with all options, is $1,151,741.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award